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Endothelin 3 Induces Skin Pigmentation in a
Keratin-Driven Inducible Mouse Model
Roman J. Garcia1, Avner Ittah1, Sheyla Mirabal1, Jessica Figueroa1, Lidice Lopez1, Adam B. Glick2 and
Lidia Kos1
Endothelin 3 (Edn3) encodes a ligand important to developing neural crest cells and is allelic to the spontaneous
mouse mutation occurring at the lethal spotting (ls) locus. Edn3ls/ls mutants exhibit a spotted phenotype due to
reduced numbers of neural crest-derived melanocyte precursors in the skin. In this study, we show that when
Edn3 is driven by the keratin 5 promoter and thereby placed proximal to melanocyte lineage cells, adult mice
manifest pigmented skin harboring dermal melanocytes. Using a tetracycline inducible system, we show that
the postnatal expression of Edn3 is required to maintain these dermal melanocytes, and that early expression of
the Edn3 transgene is important to the onset of the hyperpigmentation phenotype. Crosses into Edn3ls/ls
mutants demonstrate that the Edn3 transgene expression does not fully compensate for the endogenous
expression pattern. Crosses into tyrosine kinase receptor KitWv mutants indicate that Edn3 can partially
compensate for Kit’s role in early development. Crosses into Ay mutant mice considerably darkened their yellow
coat color suggesting a previously unreported role for endothelin signaling in pigment switching. These results
demonstrate that exogenous Edn3 affects both precursors and differentiated melanocytes, leading to a
phenotype with characteristics similar to the human skin condition dermal melanocytosis.
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INTRODUCTION
Neural crest cells (NCC) are a transient population of
epithelial cells situated over the dorsal neural tube in the
post-neurula embryo (Schoenwolf and Nichols, 1984). Some
NCC in the embryonic trunk undergo an epithelial to
mesenchymal transition, and undertake a dorsolateral mi-
gratory route between the epidermis and the dermamyotome.
These NCC eventually differentiate into the melanocytes
found in the skin (Hall, 1999; Le Douarin and Kalcheim,
1999). In the mouse, some of the NCC-derived melanocyte
precursors, the melanoblasts, remain in the dermis, while the
majority colonize the epidermal basal layer, and subse-
quently the hair follicles (Mayer, 1973; Erickson and Weston,
1983; Kunisada et al., 1996). Eventually, most of those
melanoblasts that remained in the skin are no longer present
(Kunisada et al., 2000).
Several in vitro studies have implicated a 21 amino-acid
peptide, Endothelin 3 (Edn3), with increases in the melano-
cyte lineage population and its differentiation (Lahav et al.,
1996; Reid et al., 1996; Opdecamp et al., 1998; Hou et al.,
2004; Trentin et al., 2004). In vivo, Edn3 is expressed in a
variety of tissues including the skin (Bloch et al., 1989;
Matsumoto et al., 1989; Onda et al., 1990; Reid et al., 1996).
In situ hybridization studies suggest that Edn3 is expressed
between embryonic day 8.0 (E8.0) and E15.0 in the
mesenchymal cells that surround the NCC in all parts of the
murine enteric neural and melanocyte pathways (Rice et al.,
2000).
Edn3 binds a member of the G-protein coupled heptahe-
lical superfamily called Endothelin receptor B (Ednrb) (Arai
et al., 1990; Sakurai et al., 1990; Sakamoto et al., 1993;
Yanagisawa, 1994). Ednrb is expressed in NCC including
melanoblasts (Reid et al., 1996; Opdecamp et al., 1998; Lee
et al., 2003). Ednrb and Edn3 are both allelic to the
spontaneous mouse mutations occurring at the piebald and
lethal spotting (ls) loci, respectively (Baynash et al., 1994;
Hosoda et al., 1994). Recessive mutants at either of these loci
give rise to similar phenotypes consisting of differing degrees
of hypopigmentation and aganglionic megacolon. The
hypopigmentation phenotype has been attributed to a
decrease in the melanoblast population as early as E10.5
and to abnormal cell migration identified at E11.5 (Pavan and
Tilghman, 1994; Lee et al., 2003).
The similarity between human genes and those from
model organisms has given scientists an opportunity to obtain
valuable hints about the genes involved in skin-related
pathologies. A homozygous mutation in Edn3 and a nonsense
mutation in the Ednrb locus have been linked to Waarden-
burg syndrome in humans (Hofstra et al., 1996; Syrris et al.,
1999). This syndrome comprises sensorineural hearing loss,
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hypopigmentation of the skin and hair, and pigmentary
disturbances of the irides. Mice with spontaneous mutations
in the Pax3, Sox10, Mitf, Slug, Edn3, and Ednrb genes at least
partially model elements of the four different Waardenburg
syndromes (Tachibana et al., 2003).
To investigate if higher levels of Edn3 would lead to
a novel model of melanocyte-related skin conditions, we
created transgenic mice which conditionally overexpress
Edn3. In vitro studies have previously indicated that the
effects of Edn3 signaling on melanocyte precursors are dose-
dependent (Lahav et al., 1996; Reid et al., 1996; Opdecamp
et al., 1998). Studies conducted on an Edn3 transgenic mouse
driven by the Cytokeratin 14 promoter have also been briefly
described and show that Edn3 can lead to hyperpigmented
skin (Aoki et al., 2005). To clarify the cellular and temporal
basis for this phenotype, we used the tetracycline-responsive
transgene system.
Tetracycline regulatory systems have been previously used
in several conditional expression studies in mice (Furth et al.,
1994; Chin et al., 1999; Shin et al., 1999; Diamond et al.,
2000; Jaisser, 2000). We have used K5-tTA and -rTA mice
(Diamond et al., 2000) to conditionally regulate the over-
expression of Edn3. K5-tTA or -rTA transgenic mice express
tetracycline-sensitive transcriptional activators (tTA or rTA)
under the control of the regulatory region of the Bos taurus
gene for Keratin 5 (K5).
These mice will help us clarify Edn3’s role during the
development of early embryonic melanoblasts, differentiating
melanocyte precursors in the skin, and fully differentiated
melanocytes in the hair follicle. When driven by the K5
promoter, the transgene-mediated expression of Edn3 was
predominantly confined to the roof plate of the neural tube
and surface ectoderm in embryos and postnatally in the
epidermal keratinocytes of the skin. Relative to littermate
controls, transgenics developed increased pigmentation on
most areas of the skin. Doxycycline (Dox)-based temporal
studies showed that both embryonic and postnatal events are
important for establishing and maintaining pigmented skin.
The study of our Edn3 transgenic mice may offer some insight
into the genetics behind human skin dermal pigmentation
and offer clues about the time periods important in establish-
ing these conditions.
RESULTS
A tetracycline inducible Edn3 transgene results in higher levels
of embryonic Edn3 transcripts
We have used K5-tTA and -rTA mice (Diamond et al., 2000)
to conditionally overexpress Edn3. These mice express
tetracycline-sensitive transcriptional activators (tTA or rTA)
under the control of the Bos taurus K5 promoter (Figure S1a
and b). In the absence of dox, this fusion protein comprised of
a tet-repressor-binding domain and a VP16 activation domain
(Gossen and Bujard, 1992; Resnitzky et al., 1994; Kistner
et al., 1996), binds to the TRE-Edn3-lacZ transgene which
contains a tetracycline-responsive tet-operator sequence
(tetO).
After binding tetO, the tTA protein induces transcription
from bidirectional CMV promoters (Figure S1a) and leads to
Edn3 and lacZ expression (Baron et al., 1995). However, if
dox is added to the drinking water supply, it binds to tTA and
prevents its interaction with tetO. We have also made use of
K5-rTA mice that express rTA (Figure S1b), a protein analog of
tTA that does not bind tetO unless dox is present (Kistner
et al., 1996).
Reverse transcriptase-PCR was performed on E12.5 whole
embryos (Figure S1c) and E14.5 skin (Figure S1d) to assess the
relative levels of Edn3 mRNA transcripts in K5-tTA;TRE-Edn3-
lacZ and control embryos (wild-type embryos or those
with only a single transgene). In the E12.5 embryo, Edn3
mRNA was present at slightly elevated levels in transgenics
(0.45 RU (relative units)70.02 vs 0.18 RU70.05; Po0.05).
This difference was more pronounced in the E14.5 skin
(0.39 RU70.08 vs 0.07 RU70.01; Po0.05).
K5-tTA;TRE-Edn3-lacZ mice exhibit a hyperpigmented
phenotype
The initial PCR screen of 124 tail biopsies revealed 11 TRE-
Edn3-lacZ founder mice. To obtain K5-tTA;TRE-Edn3-lacZ
mice, all TRE-Edn3-lacZ founders were crossed into K5-tTA
mice. Resultant K5-tTA;TRE-Edn3-lacZ (F1) offspring were
then mated to yield the mice, and embryos used in this study.
All K5-tTA;TRE-Edn3-lacZ mice developed a pigmented skin
phenotype.
Two highly pigmented lines (369, 476) were chosen for
detailed analysis with five and 15 transgene copy numbers,
respectively. Line 476 was specifically chosen because it did
not express lacZ during embryogenesis thereby allowing for
crosses into transgenic mice that express lacZ under the
control of the Dopachrome tautomerase (Dct) promoter.
Over 100 mice from each line were observed to develop a
hyperpigmented phenotype. Mice with just the TRE-Edn3-
lacZ transgene alone never manifested a hyperpigmentation
phenotype. As a result of their mixed genetic background
(FVB/N and C57BL/6xSJL), K5-tTA;TRE-Edn3-lacZ transgenic
mice could have a variety of coat colors (Yokoyama et al.,
1990; Brilliant et al., 1994). However, only mice with black
and agouti coats were examined in this study.
The pigment responsible for the coat color of normal mice
resides in the hair follicles and hair shafts, and not in the skin.
However, the K5-tTA;TRE-Edn3-lacZ transgenic mice deve-
loped prominent skin pigmentation (Figure 1a). Increased
pigmentation is evident at E16.5 in K5-tTA;TRE-Edn3-
lacZ(369) mice around the eye and in the muzzle around
vibrissae and within the nostrils (Figure 1b).
K5-tTA;TRE-Edn3-lacZ pups from both lines were pigmen-
ted at 0 day with varying tones of pigmentation, and in some
cases not pigmented. By 2 days (Figure 1a), the dorsal aspect,
muzzle, and most of the tail of all transgenic pups in both
lines were hyperpigmented. Control wild-type and single
transgenic mice (TRE-Edn3-lacZ(369), TRE-Edn3-lacZ(476),
or K5-tTA) did not manifest a hyperpigmented phenotype. At
10 days (Figure 1a), control mice manifested a pigmented
dorsal aspect. However, K5-tTA;TRE-Edn3-lacZ mice main-
tained a darker skin tone throughout this time, and they also
had darker pigmentation on their tail and muzzle. The dark
coloration in control mice has been shown to be due to
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pigment induction in hair follicle melanocytes as opposed to
melanocytes in the skin (Mecklenburg et al., 2000). By 20
days (Figure 1a), control mice generally took on a pink skin
tone, whereas transgenics retained their black coloration on
their dorsal and ventral aspects.
Between 20 and 40 days, the hyperpigmentation pheno-
type was still pronounced in transgenic mice. Relative to
littermate controls, K5-tTA;TRE-Edn3-lacZ mice showed
increased pigmentation on most areas of the skin such as in
the nose and muzzle, foot pads, tail (Figure 1c–e), external
genitalia, ears, and the dorsal/ventral aspects of the skin.
However, the lining of the oral cavity and paw pads were not
pigmented.
The K5-tTA;TRE-Edn3-lacZ transgene is expressed in the dorsal
aspect of the neural tube and in keratinocyte lineage cells
The lacZ expression pattern of K5-tTA;TRE-Edn3-lacZ(369)
embryos corresponded better to that generated by the human
Keratin 5 promoter (Byrne et al., 1994) than to the one
previously described for the same K5 promoter (Ramirez
et al., 1994) used in this study.
At E9.5 (Figure 2a), lacZþ cells were found in the head, in
the posterior aspect of the trunk, and tail. High levels of
b-galactosidase activity were also detected in the branchial
arches. A day later (Figure 2a), the number of lacZþ cells
increased in the branchial arches and in the trunk starting at
the level of the forelimb buds as well as in the tail. There was
also expression dorsally over the neural tube beginning at a
level just rostral of the forelimb. At E10.5, the aberrant
expression in TRE-Edn3-lacZ embryos was localized to
stained cells in the third and second branchial arch and
between the hindlimbs (Figure 2c). At E11.5 (Figure 2a) and
E12.5 (Figure 2b), embryos displayed a general increase in
lacZþ cells, and the staining in the neural tube persisted. The
aberrant expression in TRE-Edn3-lacZ(369) E12.5 embryos
was localized to stained cells in the otocysts, third branchial
arch, and between the hindlimbs (Figure 2c).
Sections of E12.5 mouse embryos (Figure 2b) revealed that
b-galactosidase activity was strongest in the surface ectoderm
and roof plate of the neural tube, with little to no staining
in the underlying mesenchyme proximal to the surface
ectoderm. In transitional areas, b-galactosidase activity was
higher in some regions of the epidermis and sparser in others,
as exemplified by the region between the lateral ridge and the
roof plate of the neural tube at the level of the forelimb
(Figure 2b).
By E15.5 (Figure 2a), the last vestiges of unstained areas in
the skin disappeared, and promoter activity could be found
over the entire surface of the embryo. Wild-type or K5-tTA
transgenic controls were negative for b-galactosidase activity
at all examined ages. E12.5 K5-tTA;TRE-Edn3-lacZ(476)
embryos did not display lacZ staining.
In the skin of the K5-tTA double transgenic mice,
b-galactosidase activity was observed in the outer root sheath
of the hair follicles and in the cornified interfollicular
epidermis. K5-tTA;TRE-Edn3-lacZ(369) skin sections from
0 day pups (Figure 2d) showed limited lacZ expression in
the epidermis coupled with strong expression in the
connective tissue underneath the integument’s striated
muscular layer. At 2 days (Figure 2e), the expression in the
connective tissue persisted and was accompanied by a more
robust and consistent epidermal lacZ expression which
included most of the hair follicles. The general localization
of this expression pattern was maintained in 20 and 90 days
adult skin.
LacZ expression was absent from wild-type and K5-tTA
mice; however, TRE-Edn3-lacZ(369) mice maintain a faint
and aberrant lacZ expression confined to small and inter-
spersed regions of the epidermis (Figure 2f). TRE-Edn3-
lacZ(476) lacZ expression is absent in 2-day-old mice and
staining in K5-tTA;TRE-Edn3-lacZ(476) mice was faint and
sparsely localized to the integument’s underlying connective
tissue (Figure 2g).
Transgenic embryos have increased melanocyte precursor
numbers
An important murine melanoblast and melanocyte marker is
Dct (Steel et al., 1992; Tsukamoto et al., 1992; Mackenzie
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Figure 1. Transgenic mice exhibit a hyperpigmentation phenotype. K5-tTA;TRE-Edn3-lacZ(369) mice (arrowheads). (a) Dorsal skin of 0, 2, 10, and 20 days
controls (wild-type) and K5-tTA;TRE-Edn3-lacZ(369) mice (not all 0 day transgenics were born with pigmentation). Hyperpigmented muzzle of (b) E16.5
and (c) 30 days mice. Adult (d) foot pads and (e) tail.
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et al., 1997; Raamsdonk et al., 2004). Since K5-tTA;TRE-
Edn3-lacZ(476) mice do not have embryonic lacZ expression,
they were crossed into Dct-lacZ mice to follow melanoblasts
during development. Whole mounts of K5-tTA;TRE-Edn3-
lacZ(476)/Dct-lacZ embryos at E12.5 did not reveal any overt
difference in melanoblast numbers and distribution. How-
ever, sections of E13.5 K5-tTA;TRE-Edn3-lacZ(476)/Dct-lacZ
transgenic embryos and Dct-lacZ littermate controls showed
that transgenics had an increased number of both dermal
(20.475.8 (SD) (n¼ 3) vs 10.173.7; Po0.001) and epider-
mal melanoblasts (24.774.8 vs 8.472.5; Po0.001; Figure
3a and b). At E16.5, melanoblasts in transgenics also
outnumbered controls in the dermis (18.974.0 vs 11.07
5.1; Po0.001) as well as in the epidermis (36.178.0 vs
29.575.7; Po0.001). A small but significant increase in the
number of Dctþ cells per hair follicle was also observed in
E16.5 transgenics (6.171.9 vs 4.670.9; Po0.001; Figure 3a
and b). Skin biopsies from 1-day-old K5-tTA;TRE-Edn3-
lacZ(476)/Dct-lacZ mice and controls were also stained for
Dct-lacZ cells (Figure 3c). Not all pigmented melanocytes
found in the skin of double transgenic animals were Dctþ .
Transgenic mice display an increased number of differentiated
melanocytes in the dermis
A histological analysis of Dopaþ cells was conducted on
0, 2, and 90-day-old K5-tTA;TRE-Edn3-lacZ(369) mice to
evaluate the presence and distribution of differentiated
melanocytes in the changing skin of juvenile and adult mice.
The dorsal aspect of the skin revealed the presence of several
melanocytes in the dermis of dark skin transgenic mice since
0 day (Figure S2a). Dopaþ cells localized to the superficial
most layer of the dermis and around the hair follicles in the
skin of 2 days transgenic mice (Figure S2b). Some melano-
cytes persist around the hair follicles in 90 days dark skin
mice (Figure S2c). Control littermates revealed considerably
fewer Dopaþ cells for all ages.
Continual transgenic Edn3 expression is required to maintain
the hyperpigmentation phenotype
Pregnant K5-tTA;TRE-Edn3-lacZ(369) dams were treated with
dox at E10.5, to identify the ensuing transgene-expressing
cells. At E11.5, K5-tTA;TRE-Edn3-lacZ embryos revealed a
significant decrease in lacZ-positive cells compared to
controls (Figures 2a and 4a). The lacZ-positive cells present
in dox-treated litters at E12.5 embryos were restricted to those
resulting from the aberrant transgene expression in TRE-Edn3-
lacZ controls (Figures 2c and 4a). Thus, the repression of
transgene expression was effective approximately 2 days after
dox administration.
The pigmentation phenotype was not induced when
the transgene was inactivated in K5-tTA;TRE-Edn3-lacZ(369)
or K5-tTA;TRE-Edn3-lacZ(476) mice by dox administration at
conception or at E12.5 (Figure 4b). When K5-tTA;TRE-Edn3-
lacZ(369) litters were treated with dox at 0 day, black
transgenic neonates gradually lost their skin color, and by 20
days they manifested the pink skin tone of controls (Figure
4c). To detect differentiated melanocytes and unmelanized
melanoblasts, skin biopsies of pink 20-day-old K5-tTA;TRE-
Edn3-lacZ(369) mice (treated with dox at 0 day) were
subjected to silver nitrate staining. Stained biopsies revealed
a reduced population of dermal melanocyte lineage cells in
relation to non-treated K5-tTA;TRE-Edn3-lacZ(369) litter-
mates (Figure 4d).
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Figure 2. Embryonic and postnatal cells expressing the tetracycline system
establish melanocytes in the dermis. (a) At E9.5, b-galactosidase activity is
absent along the trunk neural tube (arrows) in K5-tTA;TRE-Edn3-lacZ(369)
embryos. By E10.5, b-galactosidase activity begins along the neural tube and
persists during early development (E11.5). By E15.5, b-galactosidase activity
is found over most areas of the developing skin. (b) E12.5 cryosections reveal
b-galactosidase activity on the surface ectoderm (arrowhead indicates lateral
ridge) and roof plate of the neural tube (NT; bar¼ 50 mm). (c) TRE-Edn3-
lacZ(369) expressing cells in E10.5 and E12.5 embryos. (d and e) lacZ staining
in K5-tTA;TRE-Edn3-lacZ(369) skin at (d) 0 day and (e) 2 days localizes to the
epidermis, hair follicles, and underlying connective tissue. An ectopic
population of dermal melanocytes can be observed in these mice (arrows).
(f) TRE-Edn3-lacZ(369) expression in the epidermis of 2 days pups (arrow).
(g) 2 days lacZ-stained skin from the K5-tTA;TRE-Edn3-lacZ(476) line
reveals sparse to no b-galactosidase activity. Bar¼100 mm.
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Figure 3. Transgenic embryos have large numbers of Dctþ cells. Dctþ cells in Dct-lacZ control mice (C) and K5-tTA;TRE-Edn3-lacZ(476)/Dct-lacZ (Tg) mice.
(a) E13.5 and E16.5 Dctþ cells in Tg and C (TRE-Edn3-lacZ(476)/Dct-lacZ ) embryos. Sections reveal Dctþ cells scored to the dermis (horizontal arrows),
epidermis (vertical arrows), and E16.5 hair follicles (HF). (b) Number of Dctþ cells in representative areas of the dermis and epidermis of E13.5 and E16.5
embryos. E16.5 embryos were also assayed for Dctþ cells in individual hair follicles. Significant increases (asterisks; Po0.001) are seen in dermal, epidermal,
and hair follicle Dctþ cell populations. (c) Dctþ cells (arrows) localize to pigmented regions in 1-day Tg mice. Bar¼ 25mm.
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The early embryonic expression of Edn3 is important to the
onset of the hyperpigmented phenotype
The use of K5-tTA;TRE-Edn3-lacZ(369) mice does not allow
us to establish the latest time at which transgenic Edn3
expression can begin and still generate a hyperpigmented
phenotype. Therefore, K5-rTA;TRE-Edn3-lacZ(369) mice
were used to identify this time. To find the time when lacZ-
positive cells were first seen, pregnant K5-rTA;TRE-Edn3-
lacZ(369) dams were treated with dox at E7.5 and embryos
were harvested at E9.5, E10.5, and E12.5; skin biopsies were
also taken from 2-day-old mice. While E9.5 K5-rTA;TRE-
Edn3-lacZ(369) embryos did not reveal any lacZ-stained cells
(data not shown), E10.5 embryos showed b-galactosidase
activity over a large region of the embryo (Figure 5a) that
increased considerably by E12.5 (Figure 5a). Sections of
E10.5 mouse embryos at the forelimb reveals a pattern of
strong b-galactosidase activity along the surface ectoderm
and roof plate of the neural tube (Figure 5a). Thus, the onset
of transgene expression occurs approximately 3 days after
dox treatment. The 2 days transgene expression pattern in the
skin of dox-treated K5-rTA;TRE-Edn3-lacZ(369) mice is less
pronounced in the epidermis and shows little to no muscular
staining relative to K5-tTA;TRE-Edn3-lacZ(369) transgenics
(Figures 2e and 5b).
To determine when transgene expression was required
for the generation of the hyperpigmentation phenotype,
K5-rTA;TRE-Edn3-lacZ(369) mice were administered dox
since conception, at E7.5, E8.5, and E12.5. When K5-rTA;
TRE-Edn3-lacZ mice were administered dox since conception
(n¼15) or at E7.5 (n¼ 12), they revealed a phenotype similar
a
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TRE-Edn3-lacZ
K5-tTA;
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Figure 4. Transgene expression is required at all times for maintenance of the hyperpigmentation phenotype. (a) Embryos that receive dox at E10.5 lose
b-galactosidase activity over 2 days. (b) K5-tTA;TRE-Edn3-lacZ(369) embryos administered dox at E12.5 never manifest hyperpigmented skin; a 4-day-old
litter determined to have two K5-tTA;TRE-Edn3-lacZ(369) pups after PCR analysis is shown. (c) K5-tTA;TRE-Edn3-lacZ(369) mice (arrowheads) repressed with
dox at 0 day begin to lose their hyperpigmented skin. (d) Ammoniacal silver nitrate staining indicates melanocyte lineage cells (arrows) in the dark skin of a
20 days K5-tTA;TRE-Edn3-lacZ(369) mouse, and on the pink skin of a 20 days K5-tTA;TRE-Edn3-lacZ(369) littermate treated with dox at 0 day. Bar¼25 mm.
E10.5 E12.5 2d 1d
0d
a b c
d
K5-rTA;TRE-Edn3-lacZ K5-rTA;TRE-Edn3-lacZ
2d 10d 20d
Figure 5. Activation of transgene expression at E10.5 is required for the generation of the hyperpigmentation phenotype. (a) After dox induction at E7.5,
b-galactosidase activity first appears 3 days later (E10.5) and increases by E12.5. (b) Two-day-old K5-rTA;TRE-Edn3-lacZ(369) skin induced at E7.5 shows a
decreased lacZ staining pattern in the epidermis and little to no muscular staining relative to the skin of 2 days K5-tTA;TRE-Edn3-lacZ(369) mice. (c) A litter of
K5-rTA;TRE-Edn3-lacZ(369) mice treated with dox at E8.5. Three pups from this litter were identified as K5-rTA;TRE-Edn3-lacZ(369); they never developed
hyperpigmented skin. (d) K5-rTA;TRE-Edn3-lacZ(369) mice (arrowheads) induced with dox at E7.5. Bar¼ 100mm.
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to K5-tTA;TRE-Edn3-lacZ mice that were born pink or with
a slightly darker dorsal skin and ears (Figure 5d). By 2 days
(Figure 5d), these mice were substantially darker than
littermate controls, although so less than K5-tTA;TRE-Edn3-
lacZ pups. By 20 days, these mice had darkly pigmented skin
(Figure 5d) similar to K5-tTA;TRE-Edn3-lacZ mice. However,
K5-rTA;TRE-Edn3-lacZ(369) mice that were induced with dox
at E8.5 (n¼11; Figure 5c) or E12.5 (n¼9; data not shown),
did not generate hyperpigmented skin at any time.
Transgenic Edn3 alters the Edn3ls, KitWv, and Ay mutant
phenotypes
K5-tTA;TRE-Edn3-lacZ(476) mice were crossed into sponta-
neous Edn3ls, KitWv, and Ay mutants to evaluate resulting
changes in skin and coat color phenotypes. K5-tTA;TRE-
Edn3-lacZ(476)/Edn3ls/ls (n¼4) mice displayed white regions
in both the dorsal and ventral aspects of the coat (Figure 6a
and c). A partial correction of the Edn3ls/ls phenotype was
predominantly restricted to the rostral areas in transgenics
(Figure 6a and b). The skin underlying the white areas of
the coat did not display any pigmentation (Figure 6b). In an
attempt to separate the effects of the transgene on coat
pigmentation and the maintenance of the dermal population
of melanocytes, Edn3 expression was induced in K5-rTA;TRE-
Edn3-lacZ(476)/Edn3ls/ls mice since E13.5 (n¼3) (Figure 6d),
a time when melanoblasts begin to colonize the epidermis.
Neither the white areas nor the coat pigmentation in general
were altered.
An analysis of K5-tTA;TRE-Edn3-lacZ(476) mice with
either KitWv/þ or KitWv/Wv alleles allowed us to investigate
if Edn3 could compensate for Kit’s role during melanocyte
development. Heterozygous animals display a dilute coat
color with a white belly spot (Hanks et al., 1988).
Homozygous animals have an almost complete lack of
coat pigmentation. K5-tTA;TRE-Edn3-lacZ(476)/KitWv/þ mice
(n¼5) showed a normal coat indicating a rescue of
the ventral spot phenotype seen in KitWv/þ mice (Figure
6e). K5-tTA;TRE-Edn3-lacZ(476)/KitWv/Wv mice (n¼6) deve-
loped darkly pigmented skin in the rostral and caudal aspects
with a completely white coat (Figure 6f and g).
Agouti K5-tTA;TRE-Edn3-lacZ mice displayed an overtly
darkened coat phenotype relative to littermate controls. This
was due to the augmented pigmentation in both pheomelanin
and eumelanin bands in the hair shafts of transgenic mice
(Figure 6h). Ay mice have a systemic overexpression of
agouti-like transcripts that lead to a completely yellow coat
10d
a b c d
e f g
h i j
20d
20d 20d30d
7d 15d
10d 30d 20d
Figure 6. Transgene-mediated Edn3 expression alters the phenotypes of Edn3ls/ls, KitWv/Wv, and Ay mice. (a–c) K5-tTA;TRE-Edn3-lacZ(476)/Edn3ls/ls mice
(arrowheads) are shown with Edn3ls/ls littermates. (a and b) White dorsal patches in the coats (a) of 10 days K5-tTA;TRE-Edn3-lacZ(476)/Edn3ls/ls mice correlate to
(b) depigmented regions of the skin underlying these same areas in the coat. A partial correction to the spotting phenotype is seen in the rostral areas of
transgenic mice (arrows) (a and b). (c) The ventral belly spot of Edn3ls/ls mice is not rescued in 30 days K5-tTA;TRE-Edn3-lacZ(476)/Edn3ls/ls transgenics. (d) The
coat of 20 days K5-rTA;TRE-Edn3-lacZ(476)/Edn3ls/ls mice (arrowhead) induced with dox at E13.5 resembles its Edn3ls/ls littermate. (e) Rescued ventral coat
phenotype of K5-tTA;TRE-Edn3-lacZ(476)/KitWv/þ mice (arrowhead) shown with a hypopigmented KitWv/þ littermate. (f and g) K5-tTA;TRE-Edn3-lacZ(476)/
KitWv/Wv mice (arrowheads) manifest rostral and caudal areas of dark skin (arrows) at (f) 7 days; however, by (g) 15 days, these areas give rise to unpigmented
white hair follicles (arrows). (h) The dorsal agouti coat of K5-tTA;TRE-Edn3-lacZ mice (arrowhead) is darkened relative to littermate controls. Magnified
individual hair shafts are shown for each coat. (i) K5-tTA;TRE-Edn3-lacZ(476)/Ay mice (arrowhead) display a darkened coat color relative to Ay littermates.
(j) The depilated skin of K5-tTA;TRE-Edn3-lacZ(476)/Ay mice (arrowhead) develop pigmented skin in contrast to their Ay littermates. Bar¼ 15 mm.
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color (Michaud et al., 1994). K5-tTA;TRE-Edn3-lacZ(476)/Ay
mice (n¼3) (Figure 6i) were also darker than Ay littermate
controls. Their hair follicles contain eumelanin deposits in
contrast to their Ay littermates, which are pigmented only
with pheomelanin. The depilated skin of K5-tTA;TRE-Edn3-
lacZ(476)/Ay mice (Figure 6j) was hyperpigmented, but less
so than K5-tTA;TRE-Edn3-lacZ mice (Figure 1a).
DISCUSSION
In wild-type mice, only a few regions devoid of coat hair
follicles, such as the tail, pinna, and snout, actually carry an
extensive melanocyte population in the skin. Skin regions that
are covered with hair have most of their melanocytes within
hair follicles and, as a result, these areas of skin are
unpigmented (Billingham and Silvers, 1960; Hirobe, 1995).
K5-tTA;TRE-Edn3-lacZ transgenic mice developed prominent
skin pigmentation from melanocytes distributed throughout
the dermis. Transgenic mice showed increased pigmentation
on most areas of the skin, except for those areas where
melanocytes are normally not seen, such as the oral cavity and
paw pads. However, these areas were found to be pigmented in
hyperpigmented transgenic mice in which the Kit-ligand was
driven by the Cytokeratin 14 promoter (Kunisada et al., 1998).
These findings suggest that, unlike the Kit-ligand, Edn3 does not
act as a secreted chemotactic signal.
The extra Edn3 produced by the transgene and the
localization of the transgenic Edn3 signal appears to be
important to the phenotype of dark-skinned transgenics.
However, the early-development Edn3 transgene expression
pattern does not correspond to the previously described
endogenous mesenchymal Edn3 expression (Leibl et al.,
1999; Rice et al., 2000). This difference in localization is the
likely explanation for the non-rescue of the hypopigmented
coat of Edn3ls/ls mice.
Previous work with a tetracycline inducible system found
that Ednrb only needs to be transcribed in vivo between
E10–E12.5 for normal melanocyte development (Shin et al.,
1999). In these mice, the coat hair follicles are normally
pigmented. Here, we show that transgenic Edn3 needs to be
present at E10.5, for the generation of the dark skin
phenotype. Together these results indicate that the early
embryonic events important to the establishment of a fully
pigmented coat are also important to the establishment of a
hyperpigmented skin. Although the critical requirement for
endothelin signaling occurs at an early embryonic age (Shin
et al., 1999), Edn3 can have an effect on differentiated
melanocytes. Edn3, most likely, affects their survival, as
postnatal transgenic Edn3 signals from the skin were required
to maintain an extensive population of dermal melanocyte
lineage cells. Transgenic Edn3 signaling may also lead to a
hyperpigmented coat by increasing the number of hair
follicle melanocytes. The increased pigment deposits onto
the hair shaft may also suggest an increase in the pigment-
producing ability of individual hair follicle melanocytes. This
is supported by the finding that Ednrb signaling is required for
the expression of tyrosinase (Hou et al., 2004).
The synthesis of eumelanin from the hair follicle melano-
cytes of K5-tTA;TRE-Edn3-lacZ(476)/Ay mice indicates that
the Ednrb/Edn3 signaling pathway partially rescues the
inhibited Mc1-R/a-MSH pathway in the hair bulb melano-
cytes of Ay mice (Kobayashi et al., 1995; Barsh et al., 2000;
Hearing, 2000; Lassalle et al., 2003). This is additional
evidence that Edn3 signaling can influence melanocytes past
the critical time requirement, not only by affecting their
survival but also by regulating pigment switching. The lighter
pigmented skin of K5-tTA;TRE-Edn3-lacZ(476)/Ay mice rela-
tive to K5-tTA;TRE-Edn3-lacZ mice also suggests that the Ay
protein has a similar inhibitory function on the Mc1-R/a-MSH
pathway in skin melanocytes. This is further supported by
findings that show that epidermal melanocytes respond to the
agouti protein (Hirobe et al., 2004).
K5-tTA;TRE-Edn3-lacZ(476)/KitWv/Wv mice developed
darkly pigmented skin in the head and tail regions. Similarly,
when KitWv/Wv mice are crossed into those that have gain-of-
function mutations in G-proteins associated with Ednrb, the
resultant mice develop darkly pigmented ears (Raamsdonk
et al., 2004). During development, these areas contain the
highest density of melanoblasts (Pavan and Tilghman, 1994).
Adult KitWv/Wv or Ednrb null mutants exhibit some pigmenta-
tion in these same locations. Thus, as long as either the Kit or
Ednrb-mediated pathway is active, melanoblasts in areas of
high cell density can survive and differentiate.
The increased pigmentation in K5-tTA;TRE-Edn3-lacZ/
KitWv/Wv and K5-tTA;TRE-Edn3-lacZ/KitWv/þ mice suggests
that Edn3 signaling is able to partially compensate for the
dearth of melanoblasts in KitWv/Wv mutants (Mackenzie et al.,
1997). This result is similar to the white spot reduction seen in
KitW57J/W57J mutant mice with a Cytokeratin 14 promoter-
driven Edn3 transgene (Aoki et al., 2005). However, the
completely white coat found in K5-tTA;TRE-Edn3-lacZ/KitWv/
Wv mice, despite underlying areas of pigmented skin, strongly
suggests that Edn3 signaling does not compensate for one or
all of the ensuing Kit-dependent events: locating melano-
blasts for their entry and proliferation in the epidermis and the
onset of hair follicle pigmentation during anagen (Yoshida
et al., 1996).
Owing to the genetic homology between mice and
humans, the study of our Edn3 transgenic mice may offer
some insight into the genetics behind different skin-related
conditions such as benign dermal pigmentation. Endothelins,
in particular, are known to exhibit a high level of zoological
conservation (Baynash et al., 1994). Clinically, the presence
of melanocytes in the dermis is termed dermal melanocytosis
(Nordlund et al., 1998). There are several morphologic forms
of dermal melanocytosis, such as the blue nevus, the
Mongolian spot, the nevus of Ota, and the nevus of Ito
(Velez et al., 1992). Most dermal melanocytoses are
congenital such as the Mongolian spot, which typically fades
and disappears in childhood, while other cases persist for life
(Stanford and Georgouras, 1996). The genesis of dermal
melanocytosis is thought to be heterogeneous, reflecting
multiple factors or genes that regulate the development of
melanocytes (Hori and Takayama, 1988).
The transgenic mice described here suggest that Ednrb
signaling may be involved in cases of acquired dermal
melanocytosis. Acquired dermal melanocytosis appears to be
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caused by sunlight or endocrine and paracrine factors acting
on immature melanocytes in the dermis. For example,
ultraviolet irradiation is known to cause keratinocytes to
continuously secrete Endothelin 1, which along with Edn3
can bind to Ednrb (Imokawa et al., 1992; Yanagisawa, 1994;
Ahn et al., 1998). This signaling pathway is known to affect
melanocytes and accelerate melanogenesis (Mizoguchi et al.,
1997). Similarly, the continuous keratinocyte-driven expres-
sion of our Edn3 tetracycline transgenic system is required to
sustain the population of pigment-producing melanocytes in
the dermis of our transgenic mice.
MATERIALS AND METHODS
TRE-Edn3-lacZ vector construction and identification of
founder transgenic mice
A 1.4 kb BamH1 fragment containing a 1.068 kb murine Edn3 cDNA
(GenBank Accession no. U32330) was obtained after a BamH1
digestion of the DbH-edn3 plasmid (Rice et al., 2000). The BamH1
fragment was cloned into plasmid pBI-3 (Baron et al., 1995). The
resulting plasmid, pTRE-Edn3-lacZ, was digested with SapI and AclI,
yielding a 7.5 kb transgene (TRE-Edn3-lacZ) that was microinjected
into fertilized (C57BL/6XSJL)F2 eggs at the University of Michigan
Transgenic Animal Model Core (Ann Arbor, MI).
The screening of founder mice was done by PCR with primers
that yield a 463 bp product and bind to the 30 end of the Edn3 cDNA
(50-AGGCCTGTGCACACTTCTGT-30) and to non-coding DNA
(50-TCCTTGTGAAACTGGAGCCT-30) found in the original DbH-
edn3 plasmid. Transgene copy numbers were determined by
Southern blot hybridization on tail biopsy DNA. The probe, TRE-
Edn3-lacZ-P, was generated with [32P]dATP and [32P]dCTP-labeled
nucleotides from a 932 bp fragment (resulting from the SalI and
Bsu36I digestion of pTRE-Edn3-lacZ).
Mice
Mice carrying the TRE-Edn3-lacZ transgene (TRE-Edn3-lacZ) were
crossed into K5-tTA or K5-rTA mice (Diamond et al., 2000) generated
on an FVB/N genetic background. K5-tTA, TRE-Edn3-lacZ double
transgenics (K5-tTA;TRE-Edn3-lacZ) were crossed to Dct-lacZ mice
provided by Dr Paul Overbeek (Baylor College of Medicine, Houston)
created on an FVB/N background (Zhao and Overbeek, 1999), Edn3ls
(strain LS/LeJ), KitWv, and Ay mutants maintained on a C57BL/6J
background (obtained from The Jackson Laboratory, Bar Harbor, ME).
Noon of the day, a vaginal plug was found defined as E0.5.
Harvested embryos were subsequently staged according to the
standard references (Kaufman, 1995). All mice used in this study
were housed in the Animal Care Facility at Florida International
University (Miami, FL). Animal work was performed according to the
institutional guidelines established by the NIH.
Genotyping
Identification of transgenic animals and embryos was conducted by
PCR of tail biopsies or yolk sac DNA. Dct-lacZ mice (Zhao and
Overbeek, 1999) were recognized with primers that yield an 850 bp
amplicon. One primer 50-ACAAGGAAGACTGGCGAGAA-30 binds
within the Dct promoter, while the other 50-GCCGAGTTAACGCC
ATCAAAAATA-30 adheres to the lacZ gene.
K5-tTA or K5-rTA mice were genotyped with primers 50-CCAGG
TGGAGTCACAGGATT-30 and 50-ACAGAGACTGTGGACCACCC-30
that amplify a 214 bp PCR product from the regulatory region of
the Bos taurus Keratin 5 gene – GenBank accession no. Z32746
(Casatorres et al., 1994). The restriction enzyme digest, and primers
used to genotype Edn3ls (Rice et al., 2000) and KitWv mutants (Cable
et al., 1995) were described previously.
Documentation of transgene expression by reverse
transcriptase-PCR
K5-tTA;TRE-Edn3-lacZ (369 and 476) and control whole embryos or
embryonic skin were triturated, and RNA was isolated using Trizol
(Invitrogen, Carlsbad, CA) and purified with DNAse treatment to
prevent genomic DNA contamination according to the manufac-
turer’s instructions. Total RNA was used for cDNA synthesis using
the SIII reverse transcriptase (SIII-RT; Invitrogen). PCR reactions were
run for 31 cycles. Edn3 was amplified from previously described
primers (Leibl et al., 1999) to yield a 244 bp product. Levels of cDNA
were normalized with HPRT using primers (50-GGAGCGGTAGC
ACCTCCT-30 and 50-AATCCAGCAGGTCAGCAAAG-30) that yield a
311 bp size product. Each experiment was represented by two
dox-responsive embryos and littermate controls (without the TRE-
Edn3-lacZ transgene). RU values were obtained from quantified gel
images (IQ Mac v1.2). Values were obtained by dividing Edn3
mRNA levels by HPRT mRNA levels. Differences in RU values were
judged as significant if the P-value waso0.05, as determined by the
two-sample t-test (assuming equal variances).
Dox treatment
Dox (3 mg/ml; Sigma, St Louis, MO) and sucrose (5%) were added
to the drinking water of the mice subjected to transgene induction
or repression studies on the morning of the indicated experiment.
Based on the assumption that mice drink 5 ml of water every
24 hours, treated mice received 15 mg of dox daily. Each timed
dox experiment was represented by at least three litters and three
dox-responsive embryos or mice and littermate controls.
Postnatal histology
Murine skin was harvested from the medial and dorsal aspect of the
trunk and sectioned to obtain longitudinal cryosections (14 mm)
through the hair follicles (Paus et al., 1999). Mice were depilated
with Nair (Church and Dwight Co. Inc., Princeton, NJ) to expose
the integument in hairy regions. Skin samples were stained with
the Dopa reaction, lacZ stain, or for ammoniacal silver nitrate
activity and counterstained with eosin as indicated. Biopsies were
embedded in freezing medium (Triangle Biomedical Sciences,
Durham, NC) and snap-frozen in liquid nitrogen. Each age group
was represented by at least three dox-responsive transgenic mice and
three littermate controls. Every sixth section, for a total of 30 sections
(14 mm), was sampled from each mouse. Sections were photo-
graphed with a Leica DC500 digital camera mounted on a Leitz
DMRB microscope.
Dopa, silver nitrate, and b-galactosidase staining
Postnatal skin was subjected to the Dopa reaction to stain
differentiated melanocytes with tyrosinase activity according to
previously described protocols (Hirobe, 1984; Hirobe et al., 2002).
To stain melanocyte lineage cells in postnatal skin, cryosections
were rinsed in 0.05 M PBS and treated with a 10% ammoniacal silver
nitrate solution (Sigma) for 5 minutes at room temperature. This stain
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permits the light microscopy detection of differentiated melanocytes
and unmelanized melanoblasts (Hirobe, 1995).
Whole embryos or skin biopsies were stained for b-galactosidase
according to the standard protocols (Furth et al., 1994). Each lacZ
experiment was represented by at least three dox-responsive
transgenic mice and littermate controls. For the localization of
embryonic lacZþ transgene-expressing cells, 30 serial sections
(14 mm) were taken from three sites in E12.5 K5-tTA;TRE-Edn3-lacZ
embryos (the forelimb, hindlimb, and tail). E10.5 K5-rTA;TRE-Edn3-
lacZ embryos were assessed in a similar fashion at the forelimb bud.
Numerical analysis of embryonic cells
The number of epidermal, dermal, and hair follicle Dctþ cells was
quantified in cryosections obtained from K5-tTA;TRE-Edn3-lacZ/Dct-
lacZ embryos. Dctþ cells at E13.5 were determined by counting the
dorsolateral population of cells lying between the apical dorsal
aspect of the embryo to the end of the forelimb; at E16.5, the density
of Dctþ cells underlying the dorsal skin was determined by counting
those cells underneath a curve of length 1.8 mm, as measured along
the epidermis with Spot Advanced Software (Version 3.5, Diagnostic
Instruments Inc., Sterling Heights, MI). Seventy hair follicles were
analyzed per embryo. Thirty transverse serial sections (14 mm) were
made from each embryo, with the first section containing the
superior aspect of the forelimb and the others proceeding caudally.
Each age group was represented by three K5-tTA;TRE-Edn3-lacZ/
Dct-lacZ mice and three littermate controls. Means and SD were
calculated from pooled data and indicated on bar graphs.
Differences were judged as significant if the P-value was o0.001
as determined by the two-sample t-test (assuming equal variances).
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SUPPLEMENTARY MATERIAL
Figure S1. Tetracycline sensitive transcriptional activators mediate Edn3 and
lacZ transgene expression.
Figure S2. Melanocytes in the skin of transgenic mice are found mostly in the
dermis.
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